MetLife (NYSE:MET) Stock Price Target Raised at TD Cowen

MetLife (NYSE:MET) had its price objective increased by TD Cowen from $105.00 to $110.00 in a report published on Monday,Benzinga reports. They currently have a buy rating on the financial services provider’s stock.

MET has been the subject of several other reports. Piper Sandler raised shares of MetLife from a “neutral” rating to an “overweight” rating and lifted their price target for the company from $99.00 to $110.00 in a report on Tuesday, September 22nd. Wells Fargo & Company upped their price objective on shares of MetLife from $101.00 to $109.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 19th. JPMorgan Chase & Co. raised their price objective on shares of MetLife from $106.00 to $108.00 and gave the stock an “overweight” rating in a report on Tuesday, August 11th. Barclays boosted their target price on MetLife from $94.00 to $97.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. Finally, Jefferies Financial Group increased their price target on MetLife from $97.00 to $103.00 and gave the stock a “buy” rating in a research report on Friday, July 10th. Twelve investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $104.69.

MetLife Stock Performance

MetLife stock opened at $96.97 on Monday. The firm has a market capitalization of $62.39 billion, a P/E ratio of 18.58, a P/E/G ratio of 0.90 and a beta of 0.78. The stock has a fifty day moving average price of $96.54 and a two-hundred day moving average price of $86.97. MetLife has a 52-week low of $67.33 and a 52-week high of $100.93. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.20 and a quick ratio of 0.20.

MetLife (NYSE:MET) last issued its earnings results on Wednesday, August 5th. The financial services provider reported $2.43 EPS for the quarter, beating the consensus estimate of $2.30 by $0.13. MetLife had a net margin of 4.57% and a return on equity of 23.39%. The company had revenue of $13.52 billion for the quarter, compared to the consensus estimate of $19.67 billion. During the same quarter in the previous year, the company earned $2.02 EPS. The firm’s revenue for the quarter was up 10.5% compared to the same quarter last year. As a group, analysts anticipate that MetLife will post 9.83 EPS for the current fiscal year.

MetLife announced that its board has authorized a share repurchase program on Wednesday, August 5th that permits the company to buyback $3.00 billion in shares. This buyback authorization permits the financial services provider to reacquire up to 4.8% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s leadership believes its stock is undervalued.

Institutional Trading of MetLife

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Mowery & Schoenfeld Wealth Management LLC acquired a new stake in shares of MetLife during the 2nd quarter worth approximately $26,000. Burk Holdings LLC acquired a new position in MetLife in the second quarter valued at approximately $27,000. Highland Investment Advisors LLC acquired a new position in MetLife in the second quarter valued at approximately $30,000. Gunpowder Capital Management LLC dba Oliver Wealth Management bought a new position in MetLife in the fourth quarter valued at approximately $31,000. Finally, Polaris Financial Partners acquired a new stake in MetLife during the 3rd quarter worth $36,000. 94.99% of the stock is owned by institutional investors.

Trending Headlines about MetLife

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: TD Cowen raised its price target for MetLife (NYSE: MET) from $105 to $110 and upgraded or reaffirmed a “buy” rating. The new target implies approximately 13.4% upside from the referenced $96.97 level, signaling increased analyst confidence in MetLife’s earnings outlook and valuation. MetLife Price Target Raised to $110.00
• Positive Sentiment: MetLife executive Raju Tadros said employee-benefits brokers must continue evolving to remain relevant. The comments highlight the company’s focus on adapting its benefits business to changing employer and workforce needs, though they do not represent a new financial forecast or material corporate announcement. Benefits brokers must evolve to stay relevant
• Neutral Sentiment: A separate article compares MetLife with Security National Financial, but the provided information does not identify a specific development affecting MetLife’s operations, earnings, or valuation. MetLife and Security National Financial Financial Contrast
• Neutral Sentiment: Several other links refer to events or sports at MetLife Stadium, including an Arizona Cardinals game and an AC/DC concert. These references concern the venue rather than MetLife, Inc. (NYSE: MET) and should not affect the insurer’s stock.

MetLife Company Profile

MetLife, Inc is a global financial services company that provides insurance, employee benefits and retirement solutions. Its products and services include life insurance, dental and vision coverage, disability insurance, accident and health benefits, annuities, and savings and retirement products.

The company serves individuals, employers and institutions through group benefits, workplace solutions and individual insurance offerings. MetLife also provides investment and retirement services designed to help employers and employees prepare for long-term financial needs.

Founded in 1868, MetLife is headquartered in New York City and operates through businesses in the United States and international markets, including regions across Latin America, Asia and Europe.